Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1989-4-26
|
pubmed:abstractText |
Using the heterotopically transplanted rat urinary bladder, we have shown that normal rat urine has a potent tumor-enhancing effect on bladder carcinogenesis. In an attempt to isolate tumor-enhancing factor(s), urine was fractionated by Bio-Gel P-100 column chromatography and each eluate fraction was examined for inducibility of ornithine decarboxylase (ODC) in a target rat bladder carcinoma cell line, 804G. We have identified two ODC-inducible peaks, one located in a high molecular weight region designated as Fraction I (Fr. I) and the second in a low molecular weight region designated as Fraction II (Fr. II). Fr. I consisted of two principal elements, transferrin and a component which induced ODC. The present investigation was conducted to characterize the ODC-inducible activity in Fr. I and II. Chromatographic analysis of Fr. I by Sephacryl S-200 and Fr. II by Bio-Gel P-10 chromatography separated several ODC-inducible peaks. However, the major ODC inducibility was due to a high concentration (460 ng/mg Fr. I residue, approximate Mr 54,000, and 580 ng/mg Fr. II residue, approximate Mr 6,100) of epidermal growth factor (EGF) as determined by radioimmunoassay. Aliquots obtained from these peaks competed with mouse EGF for EGF receptors in A431 cells. Preincubation of Fr. I and II with rabbit anti-rat EGF IgG significantly reduced ODC inducibility. Transforming growth factor alpha activity as determined by radioimmunoassay was also demonstrated in both Fr. I (34 ng/mg) and Fr. II (9 ng/mg). The results of the present study together with our previous data indicate that the majority of the ODC-inducing activity in the tumor-enhancing urinary components Fr. I and Fr. II is due to EGF itself and EGF-related growth factors of high molecular weight and that Fr. I also contains transferrin.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0008-5472
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
49
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1548-53
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:2784351-Animals,
pubmed-meshheading:2784351-Dose-Response Relationship, Drug,
pubmed-meshheading:2784351-Enzyme Induction,
pubmed-meshheading:2784351-Epidermal Growth Factor,
pubmed-meshheading:2784351-Immunoglobulin G,
pubmed-meshheading:2784351-Male,
pubmed-meshheading:2784351-Molecular Weight,
pubmed-meshheading:2784351-Ornithine Decarboxylase,
pubmed-meshheading:2784351-Rats,
pubmed-meshheading:2784351-Rats, Inbred F344,
pubmed-meshheading:2784351-Transforming Growth Factors,
pubmed-meshheading:2784351-Urinary Bladder Neoplasms
|
pubmed:year |
1989
|
pubmed:articleTitle |
Identification of epidermal growth factor as a component of the rat urinary bladder tumor-enhancing urinary fractions.
|
pubmed:affiliation |
Department of Pathology, Northwestern University Medical School, Chicago, Illinois 60611.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|